MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 (original) (raw)

References

• Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA . (2009). Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438–1449.
  Article CAS Google Scholar
• Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S et al. (2009). MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090–9095.
  Article CAS Google Scholar
• Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271–1277.
  Article CAS Google Scholar
• Chen CZ, Li L, Lodish HF, Bartel DP . (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83–86.
  Article CAS Google Scholar
• Chen J, Yao Y, Gong C, Yu F, Su S, Liu B et al. (2011). CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell 19: 541–555.
  Article CAS Google Scholar
• Chua KN, Ma J, Thiery JP . (2008). Targeted therapies in control of EMT in carcinoma and fibrosis. Drug Discov Today 4: 261–267.
  Article Google Scholar
• Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL . (2010). BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. Int J Cancer 128: 1946–1954.
  Article Google Scholar
• Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M et al. (2007). Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187–2196.
  Article CAS Google Scholar
• Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J et al. (2005). Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23: 3562–3567.
  Article CAS Google Scholar
• Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE 3: e3148.
  Article Google Scholar
• Gosepath EM, Eckstein N, Hamacher A, Servan K, von Jonquieres G, Lage H et al. (2008). Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1. Int J Cancer 123: 2013–2019.
  Article CAS Google Scholar
• Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593–601.
  Article CAS Google Scholar
• Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628–9632.
  Article CAS Google Scholar
• Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R et al. (2006). Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118: 290–301.
  Article CAS Google Scholar
• Jagani Z, Wiederschain D, Loo A, He D, Mosher R, Fordjour P et al. (2010). The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells. Cancer Res 70: 5528–5538.
  Article CAS Google Scholar
• Jeyaseelan K, Herath WB, Armugam A . (2007). MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets 11: 1119–1129.
  Article CAS Google Scholar
• Kajita M, McClinic KN, Wade PA . (2004). Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 24: 7559–7566.
  Article CAS Google Scholar
• Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A et al. (2007). Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 31: 277–283.
  CAS PubMed Google Scholar
• Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH et al. (2004). Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13: 383–388.
  Article Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438: 685–689.
  Article Google Scholar
• Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY et al. (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059–2068.
  Article CAS Google Scholar
• Li J, Gong LY, Song LB, Jiang LL, Liu LP, Wu J et al. (2010). Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB pathway. Am J Pathol 176: 699–709.
  Article CAS Google Scholar
• Li J, Huang H, Sun L, Yang M, Pan C, Chen W et al. (2009a). MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15: 3998–4008.
  Article CAS Google Scholar
• Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S et al. (2007). Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7: 36.
  Article Google Scholar
• Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY et al. (2011). Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 18: 16–25.
  Article Google Scholar
• Li QQ, Xu JD, Wang WJ, Cao XX, Chen Q, Tang F et al. (2009b). Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res 15: 2657–2665.
  Article CAS Google Scholar
• Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C et al. (2007). Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 121: 1764–1770.
  Article CAS Google Scholar
• Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL et al. (2008). MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283: 29897–29903.
  Article CAS Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513–10518.
  Article CAS Google Scholar
• Seve P, Isaac S, Tredan O, Souquet PJ, Pacheco Y, Perol M . (2005). Expression of class III {beta}-tubulin is predictive of patient outcom. Clin Cancer Res 11: 5481–5486.
  Article CAS Google Scholar
• Shida T, Furuya M, Nikaido T, Hasegawa M, Koda K, Oda K et al. (2006). Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine carcinomas. Cancer Biol Ther 5: 1530–1538.
  Article CAS Google Scholar
• Song E, Chen J, Ouyang N, Su F, Wang M, Heemann U . (2001). Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer 85: 1047–1054.
  Article CAS Google Scholar
• Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ et al. (2009). The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626–3636.
  Article CAS Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA . (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871–890.
  Article CAS Google Scholar
• Toner M, O'Regan EM . (2009). Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2. Head Neck Pathol 3: 249–251.
  Article CAS Google Scholar
• Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS et al. (2009). Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69: 2400–2407.
  Article CAS Google Scholar
• Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487–1495.
  Article CAS Google Scholar
• Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S et al. (2008). miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372–379.
  Article CAS Google Scholar
• Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H et al. (2008). Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res 68: 516–520.
  Article CAS Google Scholar
• Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R et al. (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147–4153.
  Article CAS Google Scholar
• Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH et al. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: 982–992.
  Article Google Scholar
• Yu F, Deng H, Yao H, Liu Q, Su F, Song E . (2010). Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29: 4194–4204.
  Article CAS Google Scholar
• Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109–1123.
  Article CAS Google Scholar

Download references